Challenges Linger as Chinese Firms Kick Off R&D Race (Pt.2)

China’s pharmaceutical industry is entering a critical period of transformation as it is losing its traditional price competitiveness in the international market and is now looking more to develop its potential as a force in original R&D. New development models and innovative firms have emerged in the country in recent years, some of which shared their strategies and challenges at a recent meeting in Shanghai.